246 related articles for article (PubMed ID: 28991229)
21. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
22. Cancer cells exploit eIF4E2-directed synthesis of hypoxia response proteins to drive tumor progression.
Uniacke J; Perera JK; Lachance G; Francisco CB; Lee S
Cancer Res; 2014 Mar; 74(5):1379-89. PubMed ID: 24408918
[TBL] [Abstract][Full Text] [Related]
23. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
24. ERβ1 inhibits the migration and invasion of breast cancer cells through upregulation of E-cadherin in a Id1-dependent manner.
Zhou Y; Ming J; Xu Y; Zhang Y; Jiang J
Biochem Biophys Res Commun; 2015 Feb; 457(2):141-7. PubMed ID: 25514034
[TBL] [Abstract][Full Text] [Related]
25. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells.
Vergara D; Simeone P; Latorre D; Cascione F; Leporatti S; Trerotola M; Giudetti AM; Capobianco L; Lunetti P; Rizzello A; Rinaldi R; Alberti S; Maffia M
J Biotechnol; 2015 May; 202():3-11. PubMed ID: 25449012
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
27. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors.
Fuchs M; Hutzler P; Brunner I; Schlegel J; Mages J; Reuning U; Hapke S; Duyster J; Hirohashi S; Genda T; Sakamoto M; Uberall F; Höfler H; Becker KF; Luber B
Exp Cell Res; 2002 Jun; 276(2):129-41. PubMed ID: 12027444
[TBL] [Abstract][Full Text] [Related]
28. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
[TBL] [Abstract][Full Text] [Related]
29. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
[No Abstract] [Full Text] [Related]
30. N-cadherin expression in breast cancer: correlation with an aggressive histologic variant--invasive micropapillary carcinoma.
Nagi C; Guttman M; Jaffer S; Qiao R; Keren R; Triana A; Li M; Godbold J; Bleiweiss IJ; Hazan RB
Breast Cancer Res Treat; 2005 Dec; 94(3):225-35. PubMed ID: 16258702
[TBL] [Abstract][Full Text] [Related]
31. P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin.
Qiu Y; Liu Y; Li WH; Zhang HQ; Tian XX; Fang WG
Oncol Rep; 2018 Jan; 39(1):138-150. PubMed ID: 29115551
[TBL] [Abstract][Full Text] [Related]
32. The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
Höring E; Harter PN; Seznec J; Schittenhelm J; Bühring HJ; Bhattacharyya S; von Hattingen E; Zachskorn C; Mittelbronn M; Naumann U
Acta Neuropathol; 2012 Jul; 124(1):83-97. PubMed ID: 22249620
[TBL] [Abstract][Full Text] [Related]
33. [Effect of silencing HIF-1α by RNA interference on adhesion and invasion of the human nasopharyngeal carcinoma cell line CNE-1].
Jing S; Xu Q; Jing S; Zhao Z; Zhao Z; Wu F; Liu Q; Cheng Y; Wang J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Nov; 50(11):929-33. PubMed ID: 26887998
[TBL] [Abstract][Full Text] [Related]
34. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K
Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508
[TBL] [Abstract][Full Text] [Related]
35. The Influence of VE-Cadherin on Adhesion and Incorporation of Breast Cancer Cells into Vascular Endothelium.
Brock T; Boudriot E; Klawitter A; Großer M; Nguyen TTP; Giebe S; Klapproth E; Temme A; El-Armouche A; Breier G
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205118
[TBL] [Abstract][Full Text] [Related]
36. Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes.
Benzina S; Beauregard AP; Guerrette R; Jean S; Faye MD; Laflamme M; Maïcas E; Crapoulet N; Ouellette RJ; Robichaud GA
Oncotarget; 2017 Feb; 8(7):12052-12066. PubMed ID: 28076843
[TBL] [Abstract][Full Text] [Related]
37. Functional characterization of E- and P-cadherin in invasive breast cancer cells.
Sarrió D; Palacios J; Hergueta-Redondo M; Gómez-López G; Cano A; Moreno-Bueno G
BMC Cancer; 2009 Mar; 9():74. PubMed ID: 19257890
[TBL] [Abstract][Full Text] [Related]
38. FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.
Dikshit B; Irshad K; Madan E; Aggarwal N; Sarkar C; Chandra PS; Gupta DK; Chattopadhyay P; Sinha S; Chosdol K
Oncogene; 2013 Aug; 32(33):3798-808. PubMed ID: 22986533
[TBL] [Abstract][Full Text] [Related]
39. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro.
Radke I; Götte M; Smollich M; Scharle N; Kiesel L; Wülfing P
Arch Gynecol Obstet; 2017 Dec; 296(6):1153-1160. PubMed ID: 28980126
[TBL] [Abstract][Full Text] [Related]
40. Regulation of local expression of cell adhesion and motility-related mRNAs in breast cancer cells by IMP1/ZBP1.
Gu W; Katz Z; Wu B; Park HY; Li D; Lin S; Wells AL; Singer RH
J Cell Sci; 2012 Jan; 125(Pt 1):81-91. PubMed ID: 22266909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
